Bio Essence Corp 10-Q filing
Filed 2025-08-14 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-076353
- Form type
- 10-Q
- CIK
- 0001723059
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723059/000121390025076353/ea0252897-10q_bioessence.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bio Essence Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $281,312 | - | - |
| Cost Of Revenue | $92,080 | - | - |
| Gross Profit | $189,232 | - | - |
| Operating Income | $-143,869 | - | - |
| Net Income | $-145,888 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $1,371 | - | - |
| Total Assets | $112,692 | - | - |
| Total Liabilities | $3.2M | - | - |
| Shareholders Equity | $-3.1M | - | - |
| Operating Cash Flow | $141,728 | - | - |